腹腔镜与机器人骶骨阴道固定术后疼痛的比较
本研究为一项安慰剂对照随机对照试验的二次分析,比较腹腔镜与机器人微创骶骨阴道固定术(MISC)术后疼痛。纳入90例受试者(腹腔镜65例、机器人25例),术后24小时腹腔镜组阿片类药物用量(含术中)更高,但校正手术时间和阴道修补后差异消失,两组VAS疼痛评分、术后第一周阿片用量及生活质量无差异。
要点
- 腹腔镜组术后24小时阿片用量(含术中)高于机器人组(48.5±25.5 vs 35.1±14.6 MME,p<.01),校正混杂后差异消失。
- 两组术后24小时VAS疼痛评分、第一周阿片用量及生活质量无差异。
- 总体阿片用量、疼痛评分及阿片副作用均较低。
核心结论
- 比较腹腔镜与机器人MISC的VAS疼痛评分、MME阿片用量和生活质量,或没有差异,或差异在校正混杂因素后消失。
研究设计与样本
- 一项安慰剂对照随机对照试验(RCT)的二次分析,原试验为双盲、多中心RCT,于2014年至2017年开展。
- 共纳入90例接受MISC的女性:腹腔镜组65例,机器人组25例。
- 受试者多数为白人(97.8%)和绝经后(88.9%),平均年龄61.2±7.2岁,平均体质指数27.6±4.4 kg/m2。
主要发现
- 腹腔镜组同时行子宫切除术67% vs 机器人组60%(p=.49);腹腔镜组会阴修补术更多(15.4% vs 0%,p=.04),后壁修补术更多(18.5% vs 0%,p=.02)。
- 腹腔镜组手术时间更长(208.5±57.3 vs 143.6±21.0分钟,p<.01),住院时间更长(0.9±0.4 vs 0.7±0.4天,p=.02)。
- 包括术中阿片类药物时,腹腔镜组术后24小时阿片用量更多(48.5±25.5 vs 35.1±14.6 MME,p<.01);校正手术时间和同期阴道修补后该差异消失。
- 排除术中阿片类药物后,两组阿片用量无差异;术后24小时VAS评分、第一周阿片用量及生活质量(PROMIS疼痛干扰简表)均无差异(所有p<.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To compare postoperative pain and pain-related outcomes after laparoscopic (LS-MISC) vs robotic minimally invasive sacrocolpopexy (R-MISC). DESIGN: A secondary analysis of an original placebo-controlled randomized controlled trial (RCT) examining preoperative intravenous (IV) acetaminophen on postoperative pain after MISC. SETTING: Planned secondary analysis of multicenter RCT. PATIENTS: Women undergoing MISC. INTERVENTIONS: Coprimary outcomes at 24 hours were total opioid use in morphine milligram equivalents (MMEs) and visual analog scale (VAS) pain scores comparing LS-MISC and R-MISC. The secondary outcome was pain scores using a pain diary through 7 days after the procedure. MEASUREMENTS AND MAIN RESULTS: The original study was a double-blind, multicenter, RCT comparing IV acetaminophen with placebo that took place between 2014 and 2017. Given that the original trial was unable to show an impact from the use of IV acetaminophen, our analysis focused on the impact of surgical modality. We included 90 subjects undergoing MISC: 65 LS-MISC and 25 R-MISC. Most were Caucasian (97.8%) and postmenopausal (88.9%) with mean age of 61.2 ± 7.2 years and body mass index of 27.6 ± 4.4 kg/m2. IV acetaminophen did not affect pain in the original study and was not different between LS-MISC and R-MISC. Concomitant hysterectomy was performed in 67% (LS-MISC) vs 60% (R-MISC, p = .49). LS-MISC underwent more perineorrhaphies (15.4% vs 0%, p = .04) and posterior repairs (18.5% vs 0%, p = .02). Operative time was longer with LS-MISC (208.5 ± 57.3 vs 143.6 ± 21.0 minutes, p <.01). Length of stay was longer with LS-MISC (0.9 ± 0.4 vs 0.7 ± 0.4 days, p = .02). Women undergoing LS-MISC consumed more opioid MMEs through 24 hours when including intraoperative opioids (48.5 ± 25.5 vs 35.1 ± 14.6 MME, p <.01). Using linear regression correcting for operative time and concomitant vaginal repairs, this difference disappeared. Likewise, when intraoperative opioids were excluded, there was no difference. There were no differences in 24-hour postoperative VAS scores, opioid use in the first week, or quality of life (Patient-Reported Outcomes Measurement Information System - Pain Interference Short Form, all p <.05). CONCLUSION: When comparing VAS pain scores, MME opioid usage, and quality of life between LS-MISC and R-MISC, either there was no difference or differences disappeared after adjusting for confounders. Overall, opioid use, pain scores, and opioid side effects were low.
引用
- Nilsson W, Schmidt M, Turner L, et al. Comparing Postoperative Pain With Laparoscopic Versus Robotic Sacrocolpopexy. J Minim Invasive Gynecol. 2023. PMID: 38013160. doi:10.1016/j.jmig.2023.11.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。